| Trial ID: | L2872 |
| Source ID: | NCT06659744
|
| Associated Drug: |
New Use Of Semaglutide Injection
|
| Title: |
Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims
|
| Acronym: |
|
| Status: |
ACTIVE_NOT_RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: New use of semaglutide injection|DRUG: New initiation of sitagliptin
|
| Outcome Measures: |
Primary: Major adverse cardiac event (MACE), including myocardial infarction, stroke, and all cause death, Hazard ratio, Through study completion (1 day after cohort entry date until the first of outcome or censoring) | Other: Cataract surgery (negative control), Hazard ratio, Through study completion (1 day after cohort entry date until the first of outcome or censoring)
|
| Sponsor/Collaborators: |
Sponsor: Brigham and Women's Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
65108
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2024-10-24
|
| Completion Date: |
2024-12
|
| Results First Posted: |
|
| Last Update Posted: |
2024-12-20
|
| Locations: |
Brigham and Women's Hospital, Boston, Massachusetts, 02120, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT06659744
|
